Extended Half-Life Factor Concentrates in Haemophilia Treatment.

Transfus Med Hemother · 2026 · PMC13175579 · PMID 42146127

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

However, at least with regard to HB, a clear trend toward a better clinical outcome is apparent, if HB patients are switched to prophylaxis with EHL.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.